Cutibacterium acnes macromolecules

Multiple cellular macromolecules in Cutibacterium acnes" is not the canonical or scientifically recognized name of a specific molecular target. The phrase refers nonspecifically to the various **macromolecules** (proteins, enzymes, extracellular vesicles, metabolites, etc.) expressed or produced by the bacterium *Cutibacterium acnes*, a common resident of human skin involved in both homeostasis and diseases such as acne and atopic dermatitis[1][4][5][2][3][6]. There is no single molecule or receptor with this name; rather, research studies refer collectively to the genomic, proteomic, transcriptomic, or metabolomic features of this organism when citing "multiple macromolecules."[1][2][3]. Several classes of molecules in *C. acnes* with mechanistic and clinical relevance include: - **Enzymes and Proteases:** Involved in sebum degradation, immune activation, and tissue damage[4][5][6]. - **Virulence Factors:** Such as CAMP factors and biofilm-associated proteins[5][6]. - **Small Molecules/Metabolites:** e.g., short-chain fatty acids, propionic acid, L-carnosine, which modulate skin environment or inflammation[1][2]. - **Extracellular Vesicles (EVs):** Implicated in interkingdom signaling with pro- or anti-inflammatory effects depending on strain or phylotype[3]. Thus, this "target" is not a single recognizable therapeutic target, but rather a reference to a heterogeneous group of macromolecules produced by *C. acnes*, each with distinct experimental and pathophysiological roles. For structured scientific use or therapeutic target mapping, the focus should be shifted to specifying individual molecules or named virulence factors in *C. acnes* (e.g., "CAMP factor 1", "C. acnes lipase", "Cutibacterium acnes extracellular vesicle"), instead of the broad, unspecific collection implied in the phrase "multiple cellular macromolecules in Cutibacterium acnes".[1][2][3][5][6].